Emcure has excellent capabilities in formulation manufacturing with particular strengths to research, develop and supply finished formulations to the most demanding needs of the global markets. Emcure is today one of the largest contract manufacturers of tablets, capsules, liquids, ointments and creams in India and manufactures the key brands for some of the largest MNCs in India. Association with our principals has lasted many years and has grown over time.
Emcure has multiple formulation manufacturing facilities in close proximity to each other and a well established supply chain as well as vendor development systems that have been institutionalised over the years. All of Emcure's facilities are WHO GMP certified and ISO 9001 accredited for systems. These facilities are regularly audited by global audit teams of principals and have repeatedly measured up to their standards.
Emcure’s foray into supplies to the regulated markets commenced with the setting up of a solid dosages facility at Hinjwadi. The Hinjwadi manufacturing facility has approvals from both the UK MHRA and MCC South Africa, while the USFDA certification was received recently for the solid dosages plant.
A new world-class facility for liquid injectables has been set up to cater to the regulated markets. The Small Volume Parenterals facility has independent lines for filling pre-filled syringes, vials and ampoules. This plant has been set up as per standards and guidelines laid down by US FDA.
To cater to the demand of domestic market and emerging markets a new state of the art facility at Bari - Brahmana Jammu, India was created in 2009. This facility manufactures both solid and liquid orals.
Facility has received regulatory approvals from Local drug authority, WHO - GMP and also accreditations from various Health Authorities from Emerging Markets.